Neurocan is a new substrate for the ADAMTS12 metalloprotease: Potential implications in neuropathies
dc.creator | Fontanil T. | |
dc.creator | Mohamedi Y. | |
dc.creator | Moncada-Pazos A. | |
dc.creator | Cobo T. | |
dc.creator | Vega J.A. | |
dc.creator | Cobo J.L. | |
dc.creator | García-Suárez O. | |
dc.creator | Cobo J. | |
dc.creator | Obaya Á.J. | |
dc.creator | Cal S. | |
dc.date.accessioned | 2020-09-02T22:17:56Z | |
dc.date.accessioned | 2022-11-08T20:20:50Z | |
dc.date.available | 2020-09-02T22:17:56Z | |
dc.date.available | 2022-11-08T20:20:50Z | |
dc.date.created | 2020-09-02T22:17:56Z | |
dc.date.issued | 2019 | |
dc.identifier | 52, 5, 1003-1016 | |
dc.identifier | 10158987 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4508 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143758 | |
dc.language | en | |
dc.publisher | Cell Physiol Biochem Press GmbH & Co KG | |
dc.subject | ADAMTS | |
dc.subject | Extracellular matrix | |
dc.subject | Metalloprotease | |
dc.subject | Neurocan | |
dc.subject | Neurocanase | |
dc.subject | ADAMTS protein | |
dc.subject | ADAMTS12 protein | |
dc.subject | neurocan | |
dc.subject | unclassified drug | |
dc.subject | ADAMTS protein | |
dc.subject | ADAMTS12 protein, human | |
dc.subject | Adamts12 protein, mouse | |
dc.subject | lectin | |
dc.subject | NCAN protein, human | |
dc.subject | Ncan protein, mouse | |
dc.subject | nerve protein | |
dc.subject | proteochondroitin sulfate | |
dc.subject | proteoglycan | |
dc.subject | adult | |
dc.subject | animal cell | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | bioaccumulation | |
dc.subject | brain | |
dc.subject | cell adhesion | |
dc.subject | controlled study | |
dc.subject | embryo | |
dc.subject | extracellular matrix | |
dc.subject | H4 cell line | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | immunohistochemistry | |
dc.subject | mouse | |
dc.subject | neuropathy | |
dc.subject | newborn | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | protein cleavage | |
dc.subject | animal | |
dc.subject | biosynthesis | |
dc.subject | cell motion | |
dc.subject | cranial neuropathy | |
dc.subject | gene expression regulation | |
dc.subject | genetics | |
dc.subject | metabolism | |
dc.subject | pathology | |
dc.subject | protein degradation | |
dc.subject | tumor cell line | |
dc.subject | ADAMTS Proteins | |
dc.subject | Animals | |
dc.subject | Cell Adhesion | |
dc.subject | Cell Line, Tumor | |
dc.subject | Cell Movement | |
dc.subject | Chondroitin Sulfate Proteoglycans | |
dc.subject | Cranial Nerve Diseases | |
dc.subject | Gene Expression Regulation | |
dc.subject | Humans | |
dc.subject | Lectins, C-Type | |
dc.subject | Mice | |
dc.subject | Nerve Tissue Proteins | |
dc.subject | Proteoglycans | |
dc.subject | Proteolysis | |
dc.title | Neurocan is a new substrate for the ADAMTS12 metalloprotease: Potential implications in neuropathies | |
dc.type | Article |